As of today (2025-06-28), SILO Pharma's share price is $0.641. SILO Pharma's Tangible Book per Share of Mar. 2025 for the quarter that ended in Mar. 2025 was $0.84. Hence, SILO Pharma's Price to Tangible Book Ratio of today is 0.76.
The historical rank and industry rank for SILO Pharma's Price-to-Tangible-Book or its related term are showing as below:
SILO'
s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.65 Med: 8.2 Max: 126.58
Current: 0.76
During the past 13 years, SILO Pharma's highest Price to Tangible Book Ratio was 126.58. The lowest was 0.65. And the median was 8.20.
SILO's Price-to-Tangible-Book is ranked better than 88.32% of 1199
companies
in the Biotechnology industry
Industry Median: 2.86
vs SILO: 0.76
SILO Pharma Price-to-Tangible-Book Historical Data
The historical data trend for SILO Pharma's Price-to-Tangible-Book can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of SILO Pharma's Price-to-Tangible-Book
For the Biotechnology subindustry, SILO Pharma's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SILO Pharma's Price-to-Tangible-Book Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, SILO Pharma's Price-to-Tangible-Book distribution charts can be found below:
* The bar in red indicates where SILO Pharma's Price-to-Tangible-Book falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.
SILO Pharma Price-to-Tangible-Book Related Terms
Thank you for viewing the detailed overview of SILO Pharma's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's primary program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SILO has been successfully added to your 